勃林格殷格翰集团是世界上最大的制药公司之一。
Boehringer Ingelheim is one of the largest pharmaceutical companies in the world.
勃林格殷格翰管理层于周五向专家组提出解释意见时又掀起了这场争论。
Boehringer Ingelheim officials invoked that debate as they made their case to experts Friday.
勃林格殷格翰在中国的主要业务包括处方药、消费者自主保健药品、动物保健及国际采购，公司业务范围遍及全国各主要省市和地区。
Boehringer Ingelheim's business in China is focusing on prescription medicines, consumer healthcare, animal health and international procurement, covering major markets in the country.
在过去的数年里，勃林格殷格翰与一家名为PATH的非营利性组织合作提供一种类似的药囊，奈韦拉平被装在药囊中的一个小滴管里。
Boehringer Ingelheim has been working with the nonprofit organization PATH to offer a similar pouch for the past several years. The nevirapine is contained in a small dropper placed inside the pouch.
他们的文章是基于对勃林格殷格翰公司的思力华药粉吸入器的2008项荟萃分析，该药用于慢性阻塞性肺疾病的治疗。
Their essay was prompted by a 2008 meta-analysis of Boehringer Ingelheim's Spiriva HandiHaler that is used to treat chronic obstructive pulmonary disease, or COPD.
医药公司勃林格殷格翰集团和纽约花旗银行都为女员工引进了短期工作安排，让她们有时间去休假旅行。
Boehringer Ingelheim, a drug company, and Citi, a bank, have introduced short-term job placements to encourage women to travel.
2010年，勃林格殷格翰公司的净销售额达126亿欧元。公司将其最大业务-处方药业务销售额的24%投入于研发。
In 2010, Boehringer Ingelheim posted net sales of about 12.6 billion euro while spending almost 24% of net sales in its largest business segment Prescription Medicines on research and development.
2003年勃林格殷格翰动物保健业务在中国正式展开。
In 2003 Boehringer Ingelheim Animal Health business was launched in China.
2007年勃林格殷格翰回购合资公司中方股份获批准，公司变更为外商独资企业。
Boehringer Ingelheim in 2007 the Chinese joint venture company buy back shares is approved, the company changed to foreign-owned Enterprises.
2008年勃林格殷格翰(上海)动物保健品有限公司注册成立。
In 2008 Boehringer Ingelheim (Shanghai) Animal Health Products co., Ltd. was incorporated.
2008年勃林格殷格翰(上海)动物保健品有限公司注册成立。
In 2008 Boehringer Ingelheim (Shanghai) Animal Health Products co., Ltd. was incorporated.
应用推荐